Spring Creek Capital’s Hologic HOLX Stock Holding History

Spring Creek Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-19,767	Closed	-$786K	–	314
2018 Q2	$786K	Buy	+19,767	New	+$760K	0.09%	210

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Spring Creek Capital's HOLX Position: Q3 2018 in Review

Spring Creek Capital sold out of Hologic (HOLX) in Q3 2018, closing a stake of 19,767 shares — an estimated $786K sold.

Spring Creek Capital first reported a position in HOLX in Q2 2018 and held it in 1 quarter. The position peaked at $786K in Q2 2018. 445 funds tracked by Wall St. Rank hold HOLX as of Q3 2018.

Spring Creek Capital reported no remaining Hologic position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 19,767 Hologic shares in Q3 2018, an estimated $786K.
Spring Creek Capital first reported a position in Hologic in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Hologic position peaked at $786K in Q2 2018.
445 funds tracked by Wall St. Rank held Hologic as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.